Trust is a requirement in any successful relationship. Given the high stakes involved in creating successful pharma brands, building – or rebuilding – trusting client/agency relationships is worth a little extra effort.

Working in the rare disease space has never been more rewarding than it is today. Technology is turning what was once thought to be impossible into actual, tangible realities for physicians, patients, and families. There are many exciting advancements happening now – in real time – and even more on the horizon that demand our attention and advocacy to help bring them to light.

The first rule of rare: There are no rules. There are over 7,000 different rare diseases – each with its own symptomology, history, and clinical and political landscape. Most are virgin territory for marketers; only 5 percent have an approved treatment.

We are on the verge of a medical renaissance, a period of accelerated progress in the treatment and management of rare diseases. This reawakening also brings with it challenges that we must grapple with.

The 30th annual Manny Awards event was held on April 18, 2019, in New York City at Chelsea Piers.

The Healthcare Businesswomen’s Association (HBA) celebrated a milestone 30th anniversary of the annual Woman of the Year event on May 9, 2019, in New York City.

The pharmaceutical industry is embracing a more patient-centric approach throughout the drug development and commercialization value chain. As patients become more involved in their care and evaluate options available to them, pharma organizations are working on new care models to work more closely with the patients and not just with physicians, healthcare organizations and payers.

The U.S. Department of Health and Human Services (HHS) is considering proposing a plan that has many moving parts, one of which could potentially take the price that Medicare pays out to providers for Medicare Part B drugs and turn it on its head.

The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.